missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30171078

HGFR/c-MET Antibody (telisotuzumab) [Janelia Fluor™ 635], Novus Biologicals™

Human Monoclonal Antibody

Brand:  Novus Biologicals (Bio-Techne) NBP3-28225JF635

Product Code. 30171078

  • 3900.00 NOK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

HGFR/c-MET Monoclonal antibody specifically detects HGFR/c-MET in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
TRUSTED_SUSTAINABILITY
Specifications

Specifications

HGFR/c-MET
Monoclonal
Janelia Fluor 635
AUTS9, c-Met, EC 2.7.10, EC 2.7.10.1, hepatocyte growth factor receptor, HGF receptor, HGF/SF receptor, HGFR, Met (c-Met), met proto-oncogene (hepatocyte growth factor receptor), met proto-oncogene tyrosine kinase, oncogene MET, Proto-oncogene c-Met, RCCP2, Scatter factor receptor, SF receptor, Tyrosine-protein kinase Met
HGFR/ c-Met
0.1 mL
Cancer, Cancer Stem Cells, Cell Cycle and Replication, Cellular Markers, Oncogenes, Phospho Specific, Protein Kinase, Signal Transduction, Tyrosine Kinases
4233
Store at 4°C in the dark.
IgG1
Flow Cytometry, ELISA, Functional Assay
telisotuzumab
50mM Sodium Borate
Human
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.